The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 3 July 2006 doi:10.1084/jem.20052545
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 7, 1805-1815
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 740K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khader, S. A.
Right arrow Articles by Cooper, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khader, S. A.
Right arrow Articles by Cooper, A. M.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection

Shabaana A. Khader1, Santiago Partida-Sanchez1, Guy Bell1, Dawn M. Jelley-Gibbs1, Susan Swain1, John E. Pearl1, Nico Ghilardi2, Frederic J. deSauvage2, Frances E. Lund1, and Andrea M. Cooper1

1 Trudeau Institute, Inc., Saranac Lake, NY 12983
2 Genentech Inc., South San Francisco, CA 94080

CORRESPONDENCE Andrea M. Cooper: acooper{at}trudeauinstitute.org

Migration of dendritic cells (DCs) to the draining lymph node (DLN) is required for the activation of naive T cells. We show here that migration of DCs from the lung to the DLN after Mycobacterium tuberculosis (Mtb) exposure is defective in mice lacking interleukin (IL)-12p40. This defect compromises the ability of IL-12p40–deficient DCs to activate naive T cells in vivo; however, DCs that express IL-12p40 alone can activate naive T cells. Treatment of IL-12p40–deficient DCs with IL-12p40 homodimer (IL-12(p40)2) restores Mtb-induced DC migration and the ability of IL-12p40–deficient DCs to activate naive T cells. These data define a novel and fundamental role for IL-12p40 in the pathogen-induced activation of pulmonary DCs.


Abbreviations used: BMDC, bone marrow–derived DC; DLN, draining LN; Mtb, Mycobacterium tuberculosis; Tg, transgenic.

S. Partida-Sanchez's present address is Columbus Children's Research Institute, Columbus, OH 43205.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Dendritic cell paralysis
Heather L. Van Epps
J. Exp. Med. 2006 203: 1621. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS